Back to Journals » OncoTargets and Therapy » Volume 11

The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis

Total article views   HTML views PDF downloads Totals
14,477 Dovepress* 11,598+ 1,501 13,099
PubMed Central* 2,879 563 3,442
Totals 14,477 2,064 16,541
*Since 1 March 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed Central and Google Scholar